Brigatinib is a small-molecule compound used as an active pharmaceutical ingredient. It is designed to inhibit specific receptor tyrosine kinases, including anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1197953-54-0
5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine
active pharmaceutical ingredient
6-Methylthioguanine
metabolite of thioguanine drug
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
pharmaceutical intermediate
(3S)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride
active pharmaceutical ingredient
Z944
T-type calcium channel blocker
5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
AILRADAXUVEEIR-UHFFFAOYSA-N
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC